Skip to main content
. 2020 Sep 1;146(3):e20200567. doi: 10.1542/peds.2020-0567

TABLE 2.

CSTE NAS Case Definition Classification Criteria

Criterion Confirmed Probable Suspect
Type Type
1 2 1 2 3 4 5
Neonate
 Infant laboratory test result positive for opiates, benzodiazepines, or barbiturates X
 No or unknown infant laboratory test results X X X X X X X
 Diagnosis of NAS, chief complaint of NAS, or ≥3 signsa of neonate withdrawal X X X X X X
 One or 2 signs of neonate withdrawal X X
 Absence of another known cause or diagnosisb X X X X X X X X
Maternal
 Maternal laboratory test result positive for opiates, benzodiazepines, or barbiturates within 4 wk of delivery X X
 Maternal laboratory test result positive for nonopiate, nonbenzodiazepine, and nonbarbiturate drug of abuse within 4 wk of delivery X
 No or unknown maternal laboratory test results X X X
 Maternal history of chronic opioid use, benzodiazepine, or barbiturate within 4 wk of delivery X X
 Maternal history of chronic drug use within 4 wk of delivery (nonopioid, nonbenzodiazepine, and nonbarbiturate) X
 Maternal history of chronic drug use within 4 wk of delivery (unknown drug type) X

Adapted from Council of State and Territorial Epidemiologists. Neonatal Abstinence Syndrome Standardized Case Definition. Atlanta, GA: Council of State and Territorial Epidemiologists; 2019:19–21. Available at: https://cdn.ymaws.com/www.cste.org/resource/resmgr/2019ps/final/19-MCH-01_final_7.31.19.pdf. X, mandatory requirement for case definition type; —, not applicable.

b

Infant withdrawal signs: high-pitched cry, hypertonia, myoclonus, hyperactive Moro reflex, poor sleep, poor feeding, frequent yawning, nasal congestion, sneezing, fever, cutaneous mottling, vomiting, loose stools, seizures, and tachypnea.

c

No current exclusion list for other etiologies.